Aug 5 (Reuters) -
HHS: WINDS DOWN MRNA VACCINE DEVELOPMENT UNDER BARDA
HHS: WHILE SOME FINAL-STAGE CONTRACTS TO BE ALLOWED TO RUN THEIR COURSE, NO NEW MRNA-BASED PROJECTS WILL BE INITIATED
HHS: IN TOTAL, WIND DOWN AFFECTS 22 PROJECTS WORTH NEARLY $500 MILLION
Source text: [ID:]
Further company coverage: [ ]